Medizinische Universität Graz - Research portal
Navigation/Search
- Researchers
- Institutions
- Projects
- Publications
- Partners
- Sponsors
- Equipment
- Knowhow
- Fields of Research
"Faces" of the day:
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Zebisch, A; Sill, H.
How do non-coding RNAs impact treatment regimens currently being used in AML?
Expert Rev Anticancer Ther. 2022; 22(4):331-333
Doi: 10.1080/14737140.2022.2049764
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Zebisch Armin
- Co-authors Med Uni Graz
- Sill Heinz
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Leukemia, Myeloid, Acute - drug therapy, genetics
- MicroRNAs - administration & dosage
- RNA, Long Noncoding - administration & dosage
- Find related publications in this database (Keywords)
- Acute myeloid leukemia
- non-coding RNA
- AML risk stratification
- AML chemoresistance
- targeted therapy